Content about Pharmaceutical sciences

November 4, 2010
Walgreens is well-equipped for the future

It would be no small thing to define the retail market for wellness, much less...

WHAT IT MEANS AND WHY IT'S IMPORTANT — It would be no small thing to define the retail market for wellness, much less “own” it. But Walgreens is staking its future on its ability to do just that.

(THE NEWS: Walgreens chief: We want to own ‘well.’ For the full story, click here)

November 3, 2010
Walgreens chief: We want to own ‘well’

The healthcare landscape is changing. There’s a new value-driven consumer who has emerged and, in...

DEERFIELD, Ill. The healthcare landscape is changing. There’s a new value-driven consumer who has emerged and, in light of this, retail pharmacy giant Walgreens is in the midst of an evolution into “a retail health and daily living store” and is on a mission to “own well.” That was a key message that an optimistic Greg Wasson, Walgreens president and CEO, had for Wall Street during the company’s Analyst Day conference on Thursday in Chicago.

 

November 3, 2010
Watson's Q3 sales jump 33%

Sales for generic drug maker Watson Pharmaceuticals grew 33%, to $882.4 million, in third quarter...

MORRISTOWN, N.J. Sales for generic drug maker Watson Pharmaceuticals grew 33%, to $882.4 million, in third quarter 2010, according to an earnings report released Thursday.

 

The sales figure for the current quarter compared with $662.1 million in third quarter 2009. Profits were $105.9 million, compared with $90 million in third quarter 2009.

 

 

“Watson delivered another quarter of strong financial results and continued progress against our strategic objectives,” Watson president and CEO Paul Bisaro said.

November 2, 2010
BIO, GPhA and Sandoz testify at FDA biosimilars hearing

The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of...

SILVER SPRING, Md. The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of generic drugs, testified Wednesday at a hearing sponsored by the Food and Drug Administration to collect public and industry input on the implementation of the regulatory approval pathway for follow-on biologics included in the healthcare-reform bill.

 

November 1, 2010
Generics lift Endo’s 3Q

Strong generic sales helped Endo edge analyst expectations for the third quarter, the company noted....

CHADDS FORD, Pa. Strong generic sales helped Endo edge analyst expectations for the third quarter, the company noted.

Net income reached $54.2 million, compared with $49.4 million during the period ended Sept. 30. Net sales jumped 23% to $444.1 million, versus $361 million during the same period a year ago. Analysts had estimated sales of $443.36 million for the quarter.

November 1, 2010
Hyland's looks to have reformulated teething tablets back on the market in 2011

Hyland’s plans to have a reformulated Teething Tablets product back on the market in early...

LOS ANGELES Hyland’s plans to have a reformulated Teething Tablets product back on the market in early 2011, the company stated, following the initiation of its voluntary recall of the product last week.

 

November 1, 2010
PDX, Healthcare Data Solutions partner to provide prescriber verification process to PDX users

Retail pharmacy technology provider PDX has partnered with Healthcare Data Solutions to provide users of...

FORT WORTH, Texas Retail pharmacy technology provider PDX has partnered with Healthcare Data Solutions to provide users of the PDX Pharmacy System with access to a real-time prescriber verification process.

The companies said the integration of the PDX Pharmacy System and the HDS ProscriberPRO database would allow immediate verification of prescribers and associated profiles when a prescriber is added or before a prescription is filled, with access provided over a secure, Web-based service.

November 1, 2010
PhRMA to testify at FDA hearing

The Food and Drug Administration should ensure patient access, safety and efficacy; create a transparent...

WASHINGTON The Food and Drug Administration should ensure patient access, safety and efficacy; create a transparent and scientific regulatory structure; and enable innovation and competition when creating regulations governing follow-on biologics, according to testimony released in advance of an FDA hearing by a drug lobbying group.

October 28, 2010
Rite Aid pharmacist earns award from PPA

Rite Aid pharmacist and regional pharmacy recruiter Donna Hazel was named the 2010 Pennsylvania Pharmacist...

CAMP HILL, Pa. Rite Aid pharmacist and regional pharmacy recruiter Donna Hazel was named the 2010 Pennsylvania Pharmacist of the Year by the Pennsylvania Pharmacists Association, Rite Aid announced Friday.

October 27, 2010
Rite Aid posts same-store sales decline

Rite Aid on Thursday posted a same-store sales decrease of 1.7% for the four weeks...

October 25, 2010
Suspending oxaliplatin sales leads to loss for Hospira

The temporary discontinuation of sales of a drug used by cancer patients led to a...

LAKE FOREST, Ill. The temporary discontinuation of sales of a drug used by cancer patients led to a slight dip in sales for Hospira during third quarter 2010, but the company nonetheless had strong sales overall, according to an earnings report released Tuesday.

 

October 25, 2010
Washington State University student team wins pharmacy business plan competition

A team from a Pacific Northwest pharmacy school won a business plan competition sponsored by...

October 24, 2010
Extra! Extra! Read all about it—online!

As this issue went to press, it sure had been a busy week here at Drug Store News. And that means it was a busy week for the industry, too.

As this issue went to press, it sure had been a busy week here at Drug Store News. And that means it was a busy week for the industry, too.

October 24, 2010
Fact book touts distributors’ contribution to pharma sales

More than a quarter trillion dollars in pharmaceutical sales happened through primary healthcare distributors in...

October 24, 2010
Independents weathering tough economy, NCPA reports, with new revenue streams

Independent pharmacies in 2009 generally were able to withstand the pummeling of a major recession,...

October 24, 2010
Pharmacy crime discussed at NCPA conference

Community pharmacists got a briefing about pharmacy security from a company that has learned a...

October 24, 2010
ScriptPro to outfit NIH

Retail pharmacies aren’t the only ones embracing technology like pharmacy automation. The government is doing...

MISSION, Kan. —Retail pharmacies aren’t the only ones embracing technology like pharmacy automation. The government is doing it, too.

October 21, 2010
Hospira's generic Zosyn enters market

Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday....

LAKE FOREST, Ill. Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday.

 

The company, which specializes in generic injectables, announced the launch of piperacillin and tazobactam for injection. The drug is a generic version of Pfizer’s Zosyn.

 

 

Various versions of the drug had sales of $797 million during the 12-month period ended in August, according to IMS Health. Sandoz, the generics division of Novartis, also launched its own version of the drug Thursday.

October 20, 2010
K-V establishes generic drug subsidiary Nesher Pharmaceuticals

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday....

ST. LOUIS K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday.

 

K-V announced the establishment of Nesher Pharmaceuticals, appointing as its president Mark Hartman, who has had several positions in generic drug companies.

 

 

October 19, 2010
Good Neighbor Pharmacy donates funds to pharmacy schools

AmerisourceBergen and its community pharmacy network program, Good Neighbor Pharmacy, will fund several education and...

October 19, 2010
In sweeping overhaul of its retail mission, Rexall unveils ‘Healthy Living’ prototype

Katz Group Canada’s flagship Rexall drug store chain has unveiled a new retail format aimed...

October 19, 2010
Walgreens launches Rx savings club with Epocrates

A drug store chain and a leading provider of mobile drug reference tools and interactive...

October 18, 2010
Affirming freedom of choice for retail Rx, military seeks full drug maker discounts

It’s a ruling that could bolster the retail pharmacy industry’s long campaign to extend full...

October 18, 2010
Kinney Drugs' pharmacists address compliance issues

October is American Pharmacists Month, and Kinney Drugs has spent it educating patients about the...

October 18, 2010
Purdue Pharma supports state Rx monitoring programs

Drug maker Purdue Pharma has donated $200,000 to the National Association of State Controlled Substances...

CHARLESTON, S.C. Drug maker Purdue Pharma has donated $200,000 to the National Association of State Controlled Substances Authorities to address the abuse of prescription drugs, NASCSA said Tuesday.

 

The grant, presented at the group’s annual conference in Charleston, S.C., is designed to support state prescription drug monitoring programs. The NASCSA will be in charge of distributing the money to state agencies. Purdue is the maker of OxyContin (oxycodone), a commonly abused prescription opioid painkiller.